Literature DB >> 35251901

Portal Venous Pulsatility Index as a predictor of fibrosis in patients with non-alcoholic fatty liver disease.

Shisheng Lu1, Robyn Archard1, Linda Mcleod1, Angus Banh1, Danny Con2, Zaid Ardalan3,4, Numan Kutaiba1.   

Abstract

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a growing public health issue. Non-invasive methods to assess the fibrosis stage are limited, and biopsy remains the gold standard. The objective of our study was to assess whether the portal venous pulsatility index (VPI) can be used as a predictor of high-risk NAFLD at a tertiary referral centre for liver transplantation.
METHODS: We retrospectively reviewed patients with biopsy-proved NAFLD who had undergone a liver ultrasound scan within 1 year of biopsy at our centre from 2011 to 2019.
RESULTS: We did not find a significant correlation between the VPI and the NAFLD risk category or correlation between the VPI and degree of steatosis (P > 0.05 for both).
CONCLUSION: Since VPI can be easily obtained on routine liver ultrasound and since other studies do report a positive association with significant fibrosis, more studies are needed before it can be recommended or not in risk-stratifying NAFLD patients into high- vs. low-risk NAFLD.
© 2021 Australasian Society for Ultrasound in Medicine.

Entities:  

Keywords:  cirrhosis; high‐risk NAFLD; non‐alcoholic steatohepatitis; non‐invasive; risk stratification; ultrasound

Year:  2021        PMID: 35251901      PMCID: PMC8873617          DOI: 10.1002/ajum.12286

Source DB:  PubMed          Journal:  Australas J Ultrasound Med        ISSN: 1836-6864


  21 in total

1.  Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics.

Authors:  Ali Balci; Sinem Karazincir; Haldun Sumbas; Yasemin Oter; Ertugrul Egilmez; Tacettin Inandi
Journal:  J Clin Ultrasound       Date:  2008 Mar-Apr       Impact factor: 0.910

Review 2.  Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations.

Authors:  Giovanna Ferraioli; Vincent Wai-Sun Wong; Laurent Castera; Annalisa Berzigotti; Ioan Sporea; Christoph F Dietrich; Byung Ihn Choi; Stephanie R Wilson; Masatoshi Kudo; Richard G Barr
Journal:  Ultrasound Med Biol       Date:  2018-09-09       Impact factor: 2.998

3.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

4.  Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.

Authors:  Masoud Baikpour; Arinc Ozturk; Manish Dhyani; Nathaniel D Mercaldo; Theodore T Pierce; Joseph R Grajo; Anthony E Samir
Journal:  AJR Am J Roentgenol       Date:  2020-01-15       Impact factor: 3.959

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

6.  Assessment of Portal Venous and Hepatic Artery Haemodynamic Variation in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients.

Authors:  Padhmini Balasubramanian; Vinoth Boopathy; Ezhumalai Govindasamy; Basavaiya Prabhu Venkatesh
Journal:  J Clin Diagn Res       Date:  2016-08-01

7.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

8.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Authors:  S A Harrison; D Oliver; H L Arnold; S Gogia; B A Neuschwander-Tetri
Journal:  Gut       Date:  2008-04-04       Impact factor: 23.059

Review 9.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

10.  Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

Authors:  Stuart McPherson; Tim Hardy; Jean-Francois Dufour; Salvatore Petta; Manuel Romero-Gomez; Mike Allison; Claudia P Oliveira; Sven Francque; Luc Van Gaal; Jörn M Schattenberg; Dina Tiniakos; Alastair Burt; Elisabetta Bugianesi; Vlad Ratziu; Christopher P Day; Quentin M Anstee
Journal:  Am J Gastroenterol       Date:  2016-10-11       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.